Evdokia Anagnostou, MD, BSc

Dr. Evdokia Anagnostou is a Child Neurologist, Professor in the Department of Pediatrics at the University of Toronto, Senior Clinician Scientist and Director of the Bloorview Research Institute, and Vice President of Research at Holland Bloorview Kids Rehabilitation Hospital at University of Toronto. She leads multiple translational and clinical trials networks including the Province of Ontario Neurodevelopmental Disorders (POND) network: a multimodality translational network in neurodevelopmental conditions, KINDtrials: a national clinical trials network dedicated to neurodevelopment and pediatric disability, and the Canadian Precision Health Initiative for Neurodevelopment: a large precision health initiative. She is also a co-lead/partner of several other networks including RareKids-Can and MICYRN. She has an extensive track record of both investigator-initiated and industry sponsored clinical trials. She has been awarded >$75 M in research funding as PI and >$100M as PI/Co-Applicant/Collaborator through both national and international funding agencies. She has authored/co-authored more than 280 peer-reviewed articles (h-index 78; >30,000 citations). She has held a Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder and currently holds the Dr. Stuart D. Sims Chair in Autism.